A Phase 3, multicenter, open-label, switchover trial to assess the safety and efficacy of taliglucerase alfa, a plant cell-expressed recombinant human glucocerebrosidase, in adult and pediatric patients with Gaucher disease previously treated with imiglucerase

✍ Scribed by Pastores, Gregory M.; Petakov, Milan; Giraldo, Pilar; Rosenbaum, Hanna; Szer, Jeffrey; Deegan, Patrick B.; Amato, Dominick J.; Mengel, Eugen; Tan, Ee Shien; Chertkoff, Raul; Brill-Almon, Einat; Zimran, Ari

• Book ID: 127368137
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 614 KB
• Volume: 53
• Category: Article
• ISSN: 1079-9796
• DOI: 10.1016/j.bcmd.2014.05.004